Prostatitis secondary prevention: Difference between revisions
m Bot: Removing from Primary care |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 48: | Line 48: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Urology]] | |||
Latest revision as of 23:51, 29 July 2020
|
Prostatitis Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Prostatitis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Prostatitis secondary prevention |
|
Risk calculators and risk factors for Prostatitis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]
Overview
Secondary preventive therapies struggle due to developing resistance in the strains causing prostatitis. Fosfomycin given before urogenital procedures is helpful in preventing prostatitis. Ginsenoid has a preventive effect on chronic bacterial prostatitis but some still consider it controversial due to lack of evidence.[1]
Secondary Prevention
The following facts about secondary prevention of prostatitis must be kept in mind[2][3]
- Due to resistant strains, empiric antibiotics are not as effective in preventing episodes of prostatitis.
- Fosfomycin has bee used prophylactically in patients undergoing TURP.
- Ginsenoid is effective in preventing chronic bacterial prostatitis.
References
- ↑ Sang Hoon Kim, U.-Syn Ha, Dong Wan Sohn, Seung-Ju Lee, Hyun Woo Kim, Chang Hee Han & Yong-Hyun Cho (2012). "Preventive effect of ginsenoid on chronic bacterial prostatitis". Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 18 (5): 709–714. doi:10.1007/s10156-012-0406-7. PMID 22450878. Unknown parameter
|month=ignored (help) - ↑ Sang Hoon Kim, U.-Syn Ha, Dong Wan Sohn, Seung-Ju Lee, Hyun Woo Kim, Chang Hee Han & Yong-Hyun Cho (2012). "Preventive effect of ginsenoid on chronic bacterial prostatitis". Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 18 (5): 709–714. doi:10.1007/s10156-012-0406-7. PMID 22450878. Unknown parameter
|month=ignored (help) - ↑ B. J. Gardiner, A. A. Mahony, A. G. Ellis, N. Lawrentschuk, D. M. Bolton, P. T. Zeglinski, A. G. Frauman & M. L. Grayson (2014). "Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis?". Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 58 (4): e101–e105. doi:10.1093/cid/cit704. PMID 24170195. Unknown parameter
|month=ignored (help)